Stay updated on Pembrolizumab Effects in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Effects in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.4 replaces the previous revision (v3.5.3) on the page, indicating a minor update to the page revision metadata. No substantive study content appears to be altered.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.5.3 was added, replacing the previous v3.5.2. This update reflects an internal page framework change that does not modify the study content or results.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new publication citation (Mayerhoefer et al., Update on Liquid Biopsy) and updated the page revision to v3.5.2, with v3.5.0 removed.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed as part of the site's versioning. The study details page content and layout appear unchanged.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check99 days agoChange DetectedThe changes are limited to the site's footer: a new Revision: v3.4.2 tag and updated/removed generic operating-status notices. There is no impact on the study details, eligibility criteria, or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab Effects in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.